FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease

被引:18
|
作者
Seko, Yuya [1 ]
Yano, Kohta [1 ]
Takahashi, Aya [1 ]
Okishio, Shinya [1 ]
Kataoka, Seita [1 ]
Okuda, Keiichiroh [1 ]
Mizuno, Naoki [1 ]
Takemura, Masashi [1 ]
Taketani, Hiroyoshi [1 ]
Umemura, Atsushi [1 ]
Nishikawa, Taichiro [1 ]
Yamaguchi, Kanji [1 ]
Moriguchi, Michihisa [1 ]
Okanoue, Takeshi [2 ]
Itoh, Yoshito [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kyoto 6028566, Japan
[2] Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Osaka 5640013, Japan
关键词
nonalcoholic fatty liver disease; Type; 2; diabetes; Hepatic fibrosis; PNPLA3; RISK; POPULATION; MECHANISMS; OBESITY;
D O I
10.3390/ijms21010171
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is associated with chronic kidney disease (CKD). The aim of this retrospective study was to determine the risk factors for progression of CKD in patients with biopsy-proven NAFLD including patatin-like phospholipase domain containing 3 (PNPLA3) polymorphism. A total of 344 patients with biopsy-proven NAFLD were enrolled consecutively in this study. Multivariate analysis identified males (odds ratio (OR) 5.46), age (per 1 year, OR 1.07), and FIB-4 index (>= 1.30, OR 3.85) as factors associated with CKD. Of the 154 patients with a baseline estimated glomerular filtration rate (eGFR) >= 60 mL/min, 30 had a deterioration in CKD stage and 15 developed CKD after 3 years. Multivariate analysis identified diabetes mellitus (OR 2.44) as a risk factor for deterioration in CKD stage, while diabetes mellitus (OR 21.54) and baseline eGFR (per 1 mL/min OR 0.88) were risk factors for development of CKD. PNPLA3 did not affect the change in eGFR. In NAFLD patients, a high FIB-4 index was associated with CKD to increases in the index linked to reductions in eGFR. In order to prevent development of CKD, an appropriate therapy focusing on renal function is needed for NAFLD patients, especially those with diabetes.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated with Diabetes Mellitus Type 2
    Koullias, Emmanouil S.
    Koskinas, John
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (05) : 965 - 971
  • [22] MACHINE LEARNING MODEL CORRECTLY IDENTIFIES PATIENTS WITH ADVANCED LIVER FIBROSIS WHICH ARE INDETERMINATE BY FIB-4 INDEX IN NON-ALCOHOLIC FATTY LIVER DISEASE.
    Aggarwal, Manik
    Shreve, Jacob
    McCullough, Arthur
    GASTROENTEROLOGY, 2021, 160 (06) : S114 - S114
  • [23] Non-alcoholic fatty liver disease is associated with the prevalence of diabetic retinopathy and diabetic kidney disease in type 2 diabetes mellitus
    Wen, Xin
    Zhou, Xianghai
    Chen, Da
    Cheng, Jiayu
    Zhang, Fuhong
    Li, Xiaolei
    Sun, Jie
    Kong, Lingkun
    Ji, Linong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [24] Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus
    Padda, Jaskamal
    Khalid, Khizer
    Khedr, Anwar
    Tasnim, Fahriba
    Al-Ewaidat, Ola A.
    Cooper, Ayden Charlene
    Jean-Charles, Gutteridge
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [25] Diabetes mellitus and non-alcoholic fatty liver disease: the thread of Ariadne
    Kosmidou, Maria
    Milionis, Haralampos
    MINERVA ENDOCRINOLOGICA, 2017, 42 (02) : 109 - 121
  • [26] Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus
    Kasturiratne, Anuradhani
    Weerasinghe, Sanjaya
    Dassanayake, Anuradha S.
    Rajindrajith, Shaman
    de Silva, Arjuna P.
    Kato, Norihiro
    Wickremasinghe, A. Rajitha
    de Silva, H. Janaka
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (01) : 142 - 147
  • [27] Non-alcoholic fatty liver disease and type 2 diabetes mellitus
    Par Alajos
    Wittmann Istvan
    Par Gabriella
    ORVOSI HETILAP, 2022, 163 (21) : 815 - 825
  • [28] Non-alcoholic fatty liver disease and type 2 diabetes mellitus
    Par Alajos
    Wittmann Istvan
    Par Gabriella
    ORVOSI HETILAP, 2022, 163 (22) : 855 - 862
  • [29] HIGH PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHRONIC KIDNEY DISEASE
    Chinnadurai, Rajkumar
    Vassallo, Diana
    Ritchie, James
    Green, Darren
    Kalra, Philip
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [30] Is non-alcoholic fatty liver disease a risk factor for chronic kidney disease?
    Akahane, Takemi
    Namisaki, Tadashi
    Moriya, Kei
    Kawaratani, Hideto
    Kaji, Kosuke
    Takaya, Hiroaki
    Shimozato, Naotaka
    Sato, Shinya
    Sawada, Yasuhiko
    Nakanishi, Keisuke
    Furukawa, Masanori
    Fujinaga, Yukihisa
    Tsuji, Yuki
    Yoshiji, Hitoshi
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E288 - E288